{"id":18235,"date":"2014-07-14T10:30:00","date_gmt":"2014-07-14T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/fda-bacchetta-azienda-per-like-su-fb-e-post-su-twitter-2\/"},"modified":"2014-07-14T10:30:00","modified_gmt":"2014-07-14T08:30:00","slug":"fda-bacchetta-azienda-per-like-su-fb-e-post-su-twitter-2","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/fda-bacchetta-azienda-per-like-su-fb-e-post-su-twitter-2\/","title":{"rendered":"FDA wand company for &#039;likes&#039; on Facebook and posts on Twitter"},"content":{"rendered":"<p>&nbsp;<b><i><span style=\"font-size:10.5pt;line-height:107%; font-family:&quot;Arial&quot;,&quot;sans-serif&quot;;color:#212120\">They amount to &#039;validation&#039; and promotion of third-party claims<\/span><\/i><\/b><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt;\"><span style=\"font-size: large;\"><span style=\"font-family: BookAntiqua; color: rgb(33, 33, 32);\">The FDA has issued a warning letter to a drug company &quot;reprimanding&quot; it for, among other things, improperly &#039;Liking&#039; unapproved claims about its product on Facebook. The letter was sent to the headquarters of a company that produces nutritional supplements in Utah, Zarbee, and refers mainly to the Food, Drug and Cosmetic Act, the federal law according to which these types of products cannot be presented as a cure for a specific disease or condition. <\/span><\/span><span style=\"font-size: 12.0pt;font-family:BookAntiqua;mso-bidi-font-family:BookAntiqua;color:#212120\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt;\"><span style=\"font-size: large;\"><span style=\"font-family: BookAntiqua; color: rgb(33, 33, 32);\">If they were, the legislation argues, they would be drugs, subject to the laws of the medicines sector. Unusually, however, the FDA letter draws attention to the company&#039;s Twitter and Facebook accounts and in particular accuses it of having clicked &#039;Like&#039; on comments written by third parties on its Facebook page. <\/span><\/span><span style=\"font-size: 12.0pt;font-family:BookAntiqua;mso-bidi-font-family:BookAntiqua;color:#212120\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt;\"><span style=\"font-size: large;\"><span style=\"font-family: BookAntiqua; color: rgb(33, 33, 32);\">The FDA &#039;wanded&#039; the company for posting &#039;Likes&#039; on comments highlighting the effectiveness of its products for treating insomnia, bronchitis, pneumonia, colds and allergies. A comment cited by the FDA highlights: &quot;I have tried everything in the last 18 days, your cough syrup has made me feel so much better.&quot; <\/span><\/span><span style=\"font-size: 12.0pt;font-family:BookAntiqua;mso-bidi-font-family:BookAntiqua;color:#212120\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt;\"><span style=\"font-size: large;\"><span style=\"font-family: BookAntiqua; color: rgb(33, 33, 32);\">According to the regulator, the fact that the company clicked &#039;Like&#039; amounts to &#039;validation&#039; and promotion of personal claims posted by third parties. <\/span><\/span><span style=\"font-size: 12.0pt;font-family:BookAntiqua;mso-bidi-font-family:BookAntiqua;color:#212120\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-bottom: 0.0001pt;\"><span style=\"font-size: large;\"><span style=\"font-family: BookAntiqua; color: rgb(33, 33, 32);\">Zarbee was finally picked up for some &#039;tweets&#039; in which she invited: &quot;Try this remedy for colds and coughs&quot;: also in this case, for the FDA it is as if she had indicated that the products are drugs and not food supplements.<\/span><\/span><span style=\"font-size: 12.0pt;font-family:BookAntiqua;mso-bidi-font-family:BookAntiqua;color:#212120\"><\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\"><i><span style=\"font-size:9.0pt;line-height:107%;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;color:#212120;mso-bidi-font-weight:bold\">Barbara Di Chiara \u2013 14 July 2014 \u2013 <\/span><\/i><span style=\"font-size:9.0pt;line-height: 107%;font-family:&quot;Times New Roman&quot;,&quot;serif&quot;;color:red;mso-bidi-font-weight:bold; mso-bidi-font-style:italic\">Pharma<i>Kronos<\/p>\n<p><\/i><\/span><\/p>\n<p class=\"MsoNormal\"><i><span style=\"font-size:9.0pt;line-height:107%;font-family: &quot;Times New Roman&quot;,&quot;serif&quot;;color:red;mso-bidi-font-weight:bold\">&amp;nbsp<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp;Equivalgono a una &#8216;convalida&#8217; e alla promozione di affermazioni di terze parti La Fda ha emesso una lettera di avvertimento a un&#8217;azienda farmaceutica &#8216;rimproverandola&#8217; per aver, tra le altre cose, impropriamente cliccato &#8216;Mi piace&#8217; su alcune affermazioni non approvate circa un suo prodotto su Facebook. La lettera &egrave; stata inviata alla sede di una societ&agrave; &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-18235","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=18235"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/18235\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=18235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=18235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=18235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}